Last reviewed · How we verify
Pemphigus vulgaris
Approved treatments
- Imuran · Legacy Pharma
- Mabthera · Roche
- Mabthera · Roche
Monoclonal antibody targeting CD20 on B-lymphocytes, mediating cell lysis via CDC and ADCC. - Mabthera · Roche
Mabthera works by binding to the CD20 antigen on B-lymphocytes, triggering their destruction.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pemphigus vulgaris patent landscape — cliff calendar, originator estates, attackable patents
- Pemphigus vulgaris treatment landscape brief
- Pemphigus vulgaris treatment updates RSS
Frequently asked questions about Pemphigus vulgaris
What drugs treat Pemphigus vulgaris?
Tracked treatments include Imuran, Mabthera.
What is the treatment for Pemphigus vulgaris?
Standard treatment for Pemphigus vulgaris includes Imuran, Mabthera. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pemphigus vulgaris patent cliff · Pemphigus vulgaris CI report
- Treatment: Imuran · Legacy Pharma
- Treatment: Mabthera · Roche
- Treatment: Mabthera · Roche
- Treatment: Mabthera · Roche
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing